PULMONX CORPORATION Increase (Decrease) in Prepaid Expense and Other Assets
PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$492.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$521.00K.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $29.00K.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$627.00K, a 564.44% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $913.00K, a 1.08% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$813.00K, a 286.47% decline from fiscal 2024.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2024 was $436.00K, a 664.91% increase from fiscal 2023.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2023 was $57.00K.
- PULMONX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$780.00K, a 164.25% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$492.00K 10-Q · filed 2026-08-04 | -$1.12M derived: sum of 3 quarters · filed 2026-08-04 | -$206.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-04 | -$598.00K derived: sum of 2 quarters · filed 2026-05-04 | $315.00K derived: sum of 3 quarters · filed 2026-05-04 | -$476.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $286.00K derived: sum of 2 quarters · filed 2026-03-10 | -$505.00K derived: sum of 3 quarters · filed 2026-08-04 | -$813.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $913.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $122.00K derived: sum of 2 quarters · filed 2026-08-04 | -$186.00K 10-Q · filed 2025-11-12 | -$51.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$791.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.10M 10-Q · filed 2026-08-04 | -$964.00K derived: sum of 3 quarters · filed 2026-08-04 | -$41.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$308.00K 10-Q · filed 2026-05-04 | -$173.00K derived: sum of 2 quarters · filed 2026-05-04 | $750.00K derived: sum of 3 quarters · filed 2026-05-04 | $394.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.06M derived: sum of 2 quarters · filed 2026-03-10 | $702.00K derived: sum of 3 quarters · filed 2026-03-10 | $436.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $923.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $567.00K derived: sum of 2 quarters · filed 2025-11-12 | $301.00K 10-Q · filed 2025-11-12 | $169.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$622.00K 10-Q · filed 2025-08-01 | -$754.00K derived: sum of 3 quarters · filed 2025-08-01 | -$540.00K derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | -$266.00K 10-Q · filed 2025-05-02 | -$398.00K derived: sum of 2 quarters · filed 2025-05-02 | -$184.00K derived: sum of 3 quarters · filed 2025-05-02 | -$377.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $82.00K derived: sum of 2 quarters · filed 2025-02-25 | -$111.00K derived: sum of 3 quarters · filed 2025-02-25 | $57.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $21.00K derived: sum of 2 quarters · filed 2024-11-01 | $189.00K 10-Q · filed 2024-11-01 | $1.21M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$25.00K 10-Q · filed 2024-08-02 | $993.00K derived: sum of 3 quarters · filed 2024-08-02 | $260.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $168.00K 10-Q · filed 2024-05-03 | $1.19M derived: sum of 2 quarters · filed 2024-05-03 | $453.00K derived: sum of 3 quarters · filed 2024-05-03 | -$1.02M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $285.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.19M derived: sum of 3 quarters · filed 2024-02-27 | -$780.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | -$733.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$2.20M derived: sum of 2 quarters · filed 2023-11-03 | -$1.80M 10-Q · filed 2023-11-03 | -$2.98M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.06M 10-Q · filed 2023-08-04 | -$2.25M derived: sum of 3 quarters · filed 2023-08-04 | $365.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $406.00K 10-Q · filed 2023-05-08 | -$779.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.84M derived: sum of 3 quarters · filed 2023-05-08 | $2.02M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.43M derived: sum of 2 quarters · filed 2023-03-01 | $1.62M derived: sum of 3 quarters · filed 2023-03-01 | $1.21M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.80M derived: sum of 2 quarters · filed 2022-11-08 | $2.40M 10-Q · filed 2022-11-08 | $4.57M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$216.00K 10-Q · filed 2022-08-08 | $1.95M derived: sum of 3 quarters · filed 2022-08-08 | $1.81M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$404.00K 10-Q · filed 2022-05-09 | $1.76M derived: sum of 2 quarters · filed 2022-05-09 | $1.62M derived: sum of 3 quarters · filed 2022-05-09 | $1.60M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.03M derived: sum of 2 quarters · filed 2022-03-01 | $2.00M derived: sum of 3 quarters · filed 2022-03-01 | $1.76M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$166.00K derived: sum of 2 quarters · filed 2021-11-09 | -$412.00K 10-Q · filed 2021-11-09 | $275.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$271.00K 10-Q · filed 2021-08-10 | $416.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$246.00K 10-Q · filed 2021-05-12 | $441.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $684.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | -$3.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | -$21.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |